Nuveen LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.39M Sell
38,606
-5,690
-13% -$647K ﹤0.01% 1942
2025
Q1
$4.66M Buy
+44,296
New +$4.66M ﹤0.01% 1960